Skip to content

Collegium Pharmaceutical, Inc. COLL Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
-$2.45M+65.1%
Avanos Medical logo
Avanos MedicalAVNS
$2.4M+900%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$4.54M-12.8%
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
$12.43M+269%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$487K-84.8%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$10.22M+12,412%

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+17.9%
Enterprise value$869.67M-0.3%
P/E15.4×-6.9×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0.0×
Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s increase (decrease) in prepaid expense and other assets?
Collegium Pharmaceutical, Inc. (COLL) reported increase (decrease) in prepaid expense and other assets of -$4.13M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
Collegium Pharmaceutical, Inc.'s increase (decrease) in prepaid expense and other assets decreased by 140.2% year-over-year, from $10.27M to -$4.13M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s increase (decrease) in prepaid expense and other assets?
Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s increase (decrease) in prepaid expense and other assets has grown at a 64.6% compound annual growth rate (CAGR), from $1.09M to $7.97M.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.